OcuTerra Therapeutics
Boston
About OcuTerra Therapeutics
OcuTerra Therapeutics, Inc. is developing innovative drugs for ophthalmic diseases for which the current standard of care does not prevent or control the progression of the disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $35.0M
- Funding stage: Early Stage Venture
- Last round: Convertible Note (Jan 2024)
- Website: ocuterratx.com
- Phone: (617) 701-7382
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ocuterra-therapeutics-54250 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.